Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,343.72
(
-0.39%
)
US TECH 100
22,228.00
(
-1.22%
)
Dow Jones
45,216.14
(
0.11%
)
Brent Oil
105.73
(
-2.62%
)
Bitcoin
68,003.97
(
1.95%
)
News Focus
News Focus
Post# of 257313
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122824
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: isolution post# 25085

Tuesday, 03/07/2006 2:08:20 AM

Tuesday, March 07, 2006 2:08:20 AM

Post# of 257313
isolution: is there any particular reason for your interest in the Retaane news?

What do you think of OXGN’s still being in preclinical after all this time development on their CA4P eye drops for AMD? Do you give them a realistic chance of making these eye drops work in humans as a maintenance treatment following an intravitreal loading dose (presumably with periodic boosters). T.i.a. Dew

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today